Patent · US Active

C5aR antagonists

US8906938B2 · kind B2 · utility

27Cited by
13References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 14, 2013
Grant dateDec 9, 2014
Priority date
Expiry dateMay 14, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.